Robert Di Tullio
Vice President, Regulatory Affairs and Quality
ProteoGenix, Inc.

Robert Di Tullio is vice president, Regulatory Affairs and Quality at ProteoGenix, Inc. of Costa Mesa, CA. He has 34 years experience with both large and start-up firms in the in vitro diagnostics industry, the last 25 of which in senior regulatory and quality management positions. Prior to his position at ProteoGenix, Inc., Di Tullio was vice president, Regulatory Affairs, Quality and Clinical Affairs at Sequenom; vice president, Global Regulatory Affairs at Siemens Medical Solutions Diagnostics; and vice president, Regulatory Affairs, Clinical and Quality Systems at Diagnostic Products Corporation (DPC). For several years, Di Tullio served as an advisory board member for the Medical Device graduate degree curriculum at the University of Southern California. In 2003, Di Tullio was a guest speaker at the California Healthcare Institute's (CHI) Inaugural California Healthcare Summit. Di Tullio graduated from Saint Joseph's University in Philadelphia with a degree in biology. Di Tullio currently serves as co-chair of the AdvaMed Diagnostics Task Force and has numerous professional regulatory affairs society affiliations.